Bank of America’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,220,832
| Closed | -$104M | – | 7581 |
|
|
2019
Q4 | $104M | Buy |
1,220,832
+307,362
| +34% | +$20.5M | 0.01% | 749 |
|
|
2019
Q3 | $45.7M | Sell |
913,470
-833,188
| -48% | -$33.2M | 0.01% | 1193 |
|
|
2019
Q2 | $63.7M | Sell |
1,746,658
-604,662
| -26% | -$19.7M | 0.01% | 974 |
|
|
2019
Q1 | $65.7M | Buy |
2,351,320
+649,788
| +38% | +$15.3M | 0.01% | 940 |
|
|
2018
Q4 | $32.6M | Buy |
1,701,532
+821,162
| +93% | +$19.1M | 0.01% | 1303 |
|
|
2018
Q3 | $26.3M | Buy |
880,370
+28,640
| +3% | +$1.08M | ﹤0.01% | 1608 |
|
|
2018
Q2 | $31.3M | Buy |
851,730
+320
| +0% | +$10.4K | 0.01% | 1439 |
|
|
2018
Q1 | $28M | Sell |
851,410
-6,380
| -0.7% | -$199K | ﹤0.01% | 1496 |
|
|
2017
Q4 | $23.5M | Sell |
857,790
-198,143
| -19% | -$6.1M | ﹤0.01% | 1677 |
|
|
2017
Q3 | $39.1M | Buy |
1,055,933
+145,898
| +16% | +$5.38M | 0.01% | 1334 |
|
|
2017
Q2 | $34.6M | Buy |
910,035
+38,151
| +4% | +$1.7M | 0.01% | 1291 |
|
|
2017
Q1 | $42.6M | Buy |
871,884
+43,845
| +5% | +$2M | 0.01% | 1147 |
|
|
2016
Q4 | $28.1M | Buy |
828,039
+434,997
| +111% | +$15.4M | 0.01% | 1400 |
|
|
2016
Q3 | $14.8M | Buy |
393,042
+308,932
| +367% | +$11.6M | ﹤0.01% | 1889 |
|
|
2016
Q2 | $2.83M | Sell |
84,110
-131,615
| -61% | -$4.64M | ﹤0.01% | 3326 |
|
|
2016
Q1 | $6.85M | Buy |
215,725
+118,663
| +122% | +$3.88M | ﹤0.01% | 2493 |
|
|
2015
Q4 | $3.62M | Sell |
97,062
-59,992
| -38% | -$2.27M | ﹤0.01% | 3264 |
|
|
2015
Q3 | $5.96M | Buy |
157,054
+45,061
| +40% | +$1.58M | ﹤0.01% | 2720 |
|
|
2015
Q2 | $3.2M | Buy |
111,993
+81,741
| +270% | +$2.28M | ﹤0.01% | 3010 |
|
|
2015
Q1 | $847K | Sell |
30,252
-88,260
| -74% | -$2.48M | ﹤0.01% | 3900 |
|
|
2014
Q4 | $3.28M | Sell |
118,512
-42,349
| -26% | -$1.05M | ﹤0.01% | 2918 |
|
|
2014
Q3 | $3.59M | Buy |
160,861
+97,979
| +156% | +$2.49M | ﹤0.01% | 2879 |
|
|
2014
Q2 | $1.83M | Sell |
62,882
-53,233
| -46% | -$1.42M | ﹤0.01% | 3456 |
|
|
2014
Q1 | $3.3M | Buy |
116,115
+47,866
| +70% | +$1.58M | ﹤0.01% | 2778 |
|
|
2013
Q4 | $2.64M | Sell |
68,249
-11,216
| -14% | -$401K | ﹤0.01% | 3052 |
|
|
2013
Q3 | $2.66M | Sell |
79,465
-48,005
| -38% | -$1.53M | ﹤0.01% | 2970 |
|
|
2013
Q2 | $3.92M | Buy |
+127,470
| New | +$4.26M | ﹤0.01% | 2537 |
|
Other funds holding MDCO
Bank of America's MDCO Position: Q1 2020 in Review
Bank of America sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,220,832 shares — an estimated $104M sold.
Bank of America first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $104M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Bank of America reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Bank of America sold 1,220,832 Medicines Co shares in Q1 2020, an estimated $104M.
- Bank of America first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Bank of America's Medicines Co position peaked at $104M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Bank of America's 13F filing for Q1 2020, filed 15 May 2020.